Baker Bros. Advisors LP Molecular Templates, Inc. Transaction History

Baker Bros. Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $1.05 Million - $1.66 Million	-133,833 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $127,064 - $183,254	-14,984 Reduced 10.07%	133,833 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$9.99 - $14.41 $93,906 - $135,454	-9,400 Reduced 5.94%	148,817 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$12.28 - $17.63 $978,716 - $1.41 Million	-79,700 Reduced 33.5%	158,217 $2.18 Million
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $891,375 - $1.44 Million	-78,813 Reduced 24.88%	237,917 $3.16 Million
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $402,500 - $888,125	62,500 Added 24.58%	316,730 $4.43 Million
Q3 2018 Nov 14, 2018	BUY	$4.07 - $6.25 $739,999 - $1.14 Million	181,818 Added 251.09%	254,230 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$5.0 - $7.14 $362,060 - $517,021	72,412	72,412 $505,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $73.8M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.